In HNSCC patients with histologically confirmed lymph node metastases (T1–4N1–2M0), the median level of PFN1 in the blood serum was almost two times higher than in patients without regional metastases (T1–4N0M0) (Fig. 1D). This evidence concerns the gene PFN1 and head and neck squamous cell carcinoma.